XML 89 R72.htm IDEA: XBRL DOCUMENT v3.20.4
Equity-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Equity-based compensation [Abstract]      
Equity-based compensation expense $ 42.5 $ 48.5 $ 40.7
Income tax benefit (7.7) (9.8) (9.9)
Equity-based compensation expense, net of tax 34.8 $ 38.7 30.8
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized [Abstract]      
Compensation cost not yet recognized $ 43.0    
Compensation cost not yet recognized, period for recognition 2 years    
Number of Options (in shares):      
Options outstanding, beginning (in shares) 4,138,242    
Granted (in shares) 991,431    
Forfeitures/Expired (in shares) (44,409)    
Exercised (in shares) (1,119,812)    
Options outstanding, ending (in shares) 3,965,452 4,138,242  
Options Weighted Average Exercise Price (in dollars per share):      
Options outstanding, beginning weighted-average exercise price (in dollars per share) $ 59.39    
Grants, weighted average exercise price (in dollars per share) 100.80    
Forfeitures and Expirations, weighted average exercise price (in dollars per share) 92.54    
Exercises, weighted average exercise price (in dollars per share) 44.05    
Options outstanding, ending weighted-average exercise price (in dollars per share) $ 73.71 $ 59.39  
Options, Additional Disclosures:      
Options, exercisable (in shares) 2,192,951    
Options, vested and expected to vest, Outstanding (in shares) 1,745,547    
Options, exercisable, weighted average exercise price (in dollars per share) $ 56.63    
Options, vested and expected to vest, weighted average exercise price (in dollars per share) $ 94.70    
Options, outstanding, weighted average remaining contractual term 6 years 5 months 23 days    
Options, exercisable, weighted average remaining contractual term (years) 4 years 11 months 23 days    
Options, vested and expected to vest, outstanding, weighted average remaining contractual term (in years) 8 years 3 months 25 days    
Options, outstanding intrinsic value $ 230.3    
Options, exercisable, Intrinsic Value 164.8    
Options, vested and expected to vest, aggregate intrinsic value 64.7    
Total intrinsic value of stock options exercised $ 94.0 $ 83.0 $ 47.0
Employee Stock Option      
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized [Abstract]      
Award expiration period 10 years    
Award vesting period 3 years    
Fair Value Assumptions:      
Grant date fair value (in dollars per share) $ 20.46 $ 19.26 $ 14.80
Volatility (as percent) 25.50% 20.00% 20.00%
Risk-free rate (as percent) 0.51% 2.53% 2.75%
Expected dividend yield (as percent) 1.52% 1.23% 1.14%
Expected term (in years) 6 years 6 years 6 years
Restricted Stock Units (RSUs)      
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized [Abstract]      
Award vesting period 3 years    
Performance Share Units (PSUs)      
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized [Abstract]      
Award vesting period 3 years    
Minimum | Performance Share Units (PSUs)      
Options, Additional Disclosures:      
Potential vesting percentage range of shares 0.00%    
Maximum | Performance Share Units (PSUs)      
Options, Additional Disclosures:      
Potential vesting percentage range of shares 200.00%    
2013 Long Term Incentive Plan      
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized [Abstract]      
Number of shares authorized (in shares) 15,500,000    
Options nonvested number of shares (in shares) 3,800,000    
Number of share available for grant (in shares) 2,600,000    
Equity Awards Granted by Seller of CDW UK      
Number of Options (in shares):      
Exercised (in shares) (110,978) (456,613)